Optical Coherence Tomography News and Research

RSS

Volcano second-quarter revenues increase 36% to record $73.5 million

Volcano Corporation, a leading developer and manufacturer of precision intravascular therapy guidance tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, said today that revenues in the second quarter of 2010 increased 36 percent versus revenues in the second quarter of 2009.

30 Jul 2010

St. Jude Medical acquires LightLab Imaging

St. Jude Medical, Inc., a global medical device company, today completed the previously announced acquisition of LightLab Imaging, Inc. for approximately $90 million in cash.

7 Jul 2010

Lantis Laser to merge with Perio-Imaging

Lantis Laser Inc., announced today that it has signed a Letter of Intent to merge with Perio-Imaging Inc., a private New York based company. The merger would be an all stock transaction and closing, among other conditions, would be subject to raising the required funding to complete the proposed merged company's product development program. The name of the new merged company will be announced upon closing.

16 Jun 2010

Optical coherence tomography shows promise for multiple sclerosis diagnosis

A quick, painless eye measurement shows promise as a way to diagnose multiple sclerosis in its very early stages, and to track the effectiveness of treatments, researchers from UT Southwestern Medical Center have found in a multicenter study.

8 Jun 2010

Volcano to highlight extensive pipeline of imaging and therapy products at EuroPCR 2010

Volcano Corporation announced today the company's plans to highlight its new product launches, presence in live cases, and participation in late breaking trials during EuroPCR from May 25 – 28 in Paris.

24 May 2010

Leading cardiologist uses new imaging system

LightLab Imaging, Inc. announced today that Good Morning America featured Dr. Marco Costa, a leading interventional cardiologist and Director of the Interventional Cardiovascular Center at University Hospitals, Case Western Reserve University, using the newest imaging technology available to hospitals in the United States – Optical Coherence Tomography.

21 May 2010

Volcano reports successful completion of cases with second generation OCT catheter and system

Volcano Corporation announced today the successful completion of Optical Coherence Tomography (OCT) cases with Volcano's second generation OCT catheter and system. Pending IDE approval, Volcano plans to use this OCT system in the US and South America as part of VOILA, a U.S. regulatory trial during 2010. Commercial release of Volcano's OCT system is expected in Europe in early 2011 and in the U.S. in mid-2011.

21 May 2010

St. Jude Medical to acquire LightLab for $90M in cash

St. Jude Medical, Inc., a global medical device company, and LightLab Imaging, Inc. today announced a definitive agreement under which St. Jude Medical will acquire LightLab, a subsidiary of Goodman Co., Ltd. for approximately $90 million in cash.

20 May 2010

Xience V sales out-performing Promus in Japanese drug-eluting stent market: MRG

According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, when Abbott Vascular's Xience V and Boston Scientific's Promus entered the Japanese drug-eluting stent market in Q1 2010, both companies picked up share from competitors Medtronic and Cordis.

6 May 2010

LightLab Imaging granted FDA clearance for C7-XR Imaging System and C7 Dragonfly Imaging Catheter

LightLab Imaging, Inc., the pioneer and leader in the development of Optical Coherence Tomography (OCT) technology for vascular and other imaging applications, has received clearance from the U.S. Food and Drug Administration (FDA) for the C7-XR Imaging System and companion C7 Dragonfly Imaging Catheter.

5 May 2010

Report shows increasing rates of AMD among Asians

The May issue of Ophthalmology, the journal of the American Academy of Ophthalmology, includes a surprising, first report on increasing rates of age-related macular degeneration among Asians, and describes an innovative "bypass" laser surgery that may help many people with central retinal vein occlusion avoid serious vision loss.

3 May 2010

Tomophase receives seventh U.S. Patent for OCTIS component

Tomophase Corporation, a leading developer of non-invasive optical coherence tomography (OCT) tissue imaging devices, announced today that it has received notification of the issuance of its seventh patent: Delivering Light via Optical Waveguide and Multi-view Optical Probe Head, U. S. Patent # 7,706,646.

29 Apr 2010

ThromboGenics microplasmin Phase III program for symptomatic focal VMA meets primary endpoint

ThromboGenics NV, a biopharmaceutical company focused on the discovery and development of innovative treatments for eye disease, vascular disease and cancer, announces that its first Phase III trial with microplasmin for the non-surgical treatment of eye disease has met its primary endpoint>Europe, is due to report in the third quarter of 2010.

20 Apr 2010

Handheld SD-OCT device helps examine vitreoretinal interface in infants with SBS

Ophthalmologists examining infants for possible Shaken Baby Syndrome (SBS) found that a handheld Spectral Domain Optical Coherence Tomography (SD-OCT) device provided high-resolution images of the retina and the vitreoretinal interface in infants with SBS, reports a study in the current issue of Retina, The Journal of Retinal and Vitreous Diseases.

17 Apr 2010

Optovue founds "Eye-Give" non-profit foundation

Optovue, a pioneer in fourier/spectral-domain optical coherence tomography (OCT), has founded "Eye-Give," a non-profit foundation for the purposes of donating technology and funding to sight saving charities and organizations around the world.

13 Apr 2010

OptiMedica releases new details on femtosecond laser system for cataract surgery

OptiMedica Corp., a global ophthalmic device company, has released new details regarding the development of its proprietary femtosecond laser system for cataract surgery. The new system, which combines OptiMedica's breakthrough pattern scanning technology, an ultra-fast laser and integrated Optical Coherence Tomography imaging, is designed to dramatically improve the complex cataract procedure by replacing its most technically demanding and manual steps.

12 Apr 2010

New studies supporting Teva Pharmaceutical Industries' CNS portfolio to be presented at AAN 2010

Teva Pharmaceutical Industries Ltd. today announced that several new studies supporting the company's innovative central nervous system portfolio will be presented at the 62nd American Academy of Neurology Annual Meeting in Toronto, April 10-17, 2010.

8 Apr 2010

MGH to create registry of patients who had OCT of coronary arteries

Massachusetts General Hospital, together with a coalition of 20 international sites in five countries, will create the world's largest registry of patients who have had optical coherence tomography of the coronary arteries.

26 Mar 2010

Stentys receives CE Marking for its self-expanding and disconnectable stent

Medical device pioneer Stentys announced today that it has received CE Marking for its self-expanding and disconnectable stent to treat acute coronary syndrome (ACS).

5 Mar 2010

Judge schedules next phase of LightLab Imaging's damages trial against Volcano and Axsun Technologies

LightLab Imaging, Inc., pioneer and leader in the development of Optical Coherence Tomography (OCT) for coronary artery applications, today reported that Trial Judge Margaret Hinkle has set March 22 for the commencement of the next phase of an ongoing trial to address damages LightLab Imaging is claiming against Volcano Corporation and its wholly owned subsidiary, Axsun Technologies, Inc.

10 Feb 2010